Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0170 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0170 |
Peptide Name | ASA-Tat |
PEPTIDE SEQUENCE (1-letter) | YGRKKRRQRRR |
PEPTIDE SEQUENCE (3-letter) | TyrGlyArgLysLysArgArgGlnArgArgArg |
N-terminal modification | Conjugated with ASA drug |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 11 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | NA |
SMILES | NA |
Cell Line | PBCECs cell line |
In vitro CONCENTRATION | 0.02% cells were added |
In vitro METHOD | Basolateral screening assay |
In vitro RESULT | 100% transfer |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | NA |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | NA |
TRANSPORT TYPE | Basolateral |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | NA |
PHYSICAL CONDITION | Lysosomal disorder |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 24573272 |